Total Payments
$126,680
2024 Payments
$5,937
Companies
11
Transactions
213
Medicare Patients
579
Medicare Billing
$145,161
Payment Breakdown by Category
Other$104,824 (82.7%)
Travel$15,149 (12.0%)
Food & Beverage$5,680 (4.5%)
Consulting$1,000 (0.8%)
Education$26.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,101 | 34 | 61.7% |
| Honoraria | $26,723 | 13 | 21.1% |
| Travel and Lodging | $15,149 | 76 | 12.0% |
| Food and Beverage | $5,680 | 79 | 4.5% |
| Consulting Fee | $1,000 | 1 | 0.8% |
| Education | $26.96 | 10 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chiesi USA, Inc. | $96,920 | 164 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $16,710 | 28 | $0 (2018) |
| La Jolla Pharmaceutical Company | $9,799 | 5 | $0 (2018) |
| Medtronic Vascular, Inc. | $1,435 | 6 | $0 (2017) |
| Ceribell, Inc. | $1,176 | 2 | $0 (2019) |
| UCB, Inc. | $159.60 | 1 | $0 (2024) |
| Integra LifeSciences Corporation | $155.40 | 2 | $0 (2022) |
| SANOFI US SERVICES INC. | $150.34 | 2 | $0 (2019) |
| Edwards Lifesciences Corporation | $126.62 | 1 | $0 (2017) |
| Corium, LLC | $31.46 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,937 | 9 | Chiesi USA, Inc. ($5,778) |
| 2023 | $7,210 | 6 | Chiesi USA, Inc. ($7,178) |
| 2022 | $12,104 | 13 | Chiesi USA, Inc. ($12,081) |
| 2021 | $11,803 | 22 | Chiesi USA, Inc. ($11,803) |
| 2020 | $5,849 | 14 | CHIESI USA, INC. ($5,833) |
| 2019 | $8,117 | 23 | Chiesi USA, Inc. ($6,967) |
| 2018 | $55,617 | 94 | Chiesi USA, Inc. ($28,931) |
| 2017 | $20,043 | 32 | Chiesi USA, Inc. ($18,348) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,730.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Travel and Lodging | Cash or cash equivalent | $29.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $159.60 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Chiesi USA, Inc. | — | Food and Beverage | In-kind items and services | $65.00 | General |
| 10/02/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $93.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,730.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Travel and Lodging | Cash or cash equivalent | $29.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $87.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/08/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Honoraria | Cash or cash equivalent | $910.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,045.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 09/26/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $82.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,045.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/19/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $96.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Honoraria | Cash or cash equivalent | $6,900.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $191.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $85.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $85.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Travel and Lodging | Cash or cash equivalent | $244.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/19/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/06/2022 | Integra LifeSciences Corporation | CODMAN CERTAS (Device), CUSA CLARITY, CODMAN HAKIM | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Neuro Critical Care | ||||||
| 03/10/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Honoraria | Cash or cash equivalent | $1,163.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/06/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Honoraria | Cash or cash equivalent | $2,600.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 127 | 240 | $118,938 | $37,701 |
| 2022 | 5 | 162 | 250 | $111,097 | $34,725 |
| 2021 | 5 | 155 | 255 | $103,801 | $33,012 |
| 2020 | 5 | 135 | 296 | $129,009 | $39,723 |
Total Patients
579
Total Services
1,041
Medicare Billing
$145,161
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 102 | 212 | $111,116 | $35,152 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 15 | $4,283 | $1,399 | 32.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 13 | $3,539 | $1,150 | 32.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 81 | 162 | $86,184 | $26,994 | 31.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $10,824 | $3,284 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 22 | 28 | $7,000 | $2,192 | 31.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 14 | 15 | $4,005 | $1,273 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 12 | $3,084 | $980.91 | 31.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 63 | 136 | $72,817 | $23,407 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 68 | $17,105 | $5,227 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 26 | $8,583 | $2,674 | 31.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 11 | 11 | $2,848 | $916.30 | 32.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 14 | $2,448 | $787.64 | 32.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 64 | 190 | $104,114 | $32,117 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 49 | $13,173 | $4,096 | 31.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 12 | 22 | $6,057 | $1,761 | 29.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 22 | $3,922 | $1,276 | 32.5% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 13 | 13 | $1,743 | $471.66 | 27.1% |
About Dr. Ali Seifi, MD
Dr. Ali Seifi, MD is a Neurocritical Care healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1295960953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Seifi, MD has received a total of $126,680 in payments from pharmaceutical and medical device companies, with $5,937 received in 2024. These payments were reported across 213 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($78,101).
As a Medicare-enrolled provider, Seifi has provided services to 579 Medicare beneficiaries, totaling 1,041 services with total Medicare billing of $145,161. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurocritical Care
- Location San Antonio, TX
- Active Since 05/26/2009
- Last Updated 11/08/2016
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1295960953
Products in Payments
- CLEVIPREX (Drug) $96,634
- BEVYXXA (Drug) $13,279
- GIAPREZA (Drug) $9,799
- ANDEXXA (Drug) $3,431
- Briviact (Drug) $159.60
- NO PRODUCT DISCUSSED (Drug) $150.34
- Licox (Device) $132.36
- KENGREAL (Drug) $128.77
- EV1000 Clinical Platform (Device) $126.62
- CLEVIPREX 25MG/50ML (Drug) $91.96
- Adlarity (Drug) $31.46
- CODMAN CERTAS (Device) $23.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurocritical Care Doctors in San Antonio
Paola Martinez, M.d, M.D
Neurocritical Care — Payments: $856.87
Neurocritical Care $856.87
Dr. Christopher Burdick, Md, MD
Neurocritical Care — Payments: $422.41
Neurocritical Care $422.41
Shaheryar Hafeez, Md, MD
Neurocritical Care — Payments: $363.49
Neurocritical Care $363.49
Dr. Sorleen Trevino, Md, Mba, MD, MBA
Neurocritical Care — Payments: $291.57
Neurocritical Care $291.57